The Cytoskeletal Protein Zyxin Inhibits Retinoic Acid Signaling by Destabilizing the Maternal mRNA of the RXRγ Nuclear Receptor.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 May 2022
Historique:
received: 19 04 2022
revised: 13 05 2022
accepted: 15 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Zyxin is an LIM-domain-containing protein that regulates the assembly of F-actin filaments in cell contacts. Additionally, as a result of mechanical stress, Zyxin can enter nuclei and regulate gene expression. Previously, we found that Zyxin could affect mRNA stability of the maternally derived stemness factors of Pou5f3 family in Xenopus laevis embryos through binding to Y-box factor1. In the present work, we demonstrate that Zyxin can also affect mRNA stability of the maternally derived retinoid receptor Rxrγ through the same mechanism. Moreover, we confirmed the functional link between Zyxin and Rxrγ-dependent gene expression. As a result, Zyxin appears to play an essential role in the regulation of the retinoic acid signal pathway during early embryonic development. Besides, our research indicates that the mechanism based on the mRNA destabilization by Zyxin may take part in the control of the expression of a fairly wide range of maternal genes.

Identifiants

pubmed: 35628438
pii: ijms23105627
doi: 10.3390/ijms23105627
pmc: PMC9147113
pii:
doi:

Substances chimiques

Cytoskeletal Proteins 0
RNA, Messenger, Stored 0
Retinoid X Receptor gamma 0
Zyxin 0
Tretinoin 5688UTC01R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Foundation for Basic Research
ID : 20-34-90017

Références

J Cell Physiol. 2011 Feb;226(2):322-30
pubmed: 20836077
FEBS J. 2023 Jan;290(1):66-72
pubmed: 34854244
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):413-425
pubmed: 30657586
Cell Adh Migr. 2007 Jan-Mar;1(1):13-8
pubmed: 19262093
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25532-25542
pubmed: 32989126
Dev Biol. 2013 Aug 1;380(1):37-48
pubmed: 23685334
Genes Dev. 1994 Dec 15;8(24):3068-79
pubmed: 8001825
STAR Protoc. 2021 Apr 21;2(2):100449
pubmed: 33997802
Gene. 2002 Feb 20;285(1-2):279-86
pubmed: 12039055
Biochim Biophys Acta. 2003 Feb 17;1593(2-3):115-20
pubmed: 12581855
Development. 2019 Jul 4;146(13):
pubmed: 31273085
STAR Protoc. 2021 May 24;2(2):100552
pubmed: 34195668
Cancer Lett. 2013 May 1;331(2):192-9
pubmed: 23321499
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):30-4
pubmed: 8380496
Wound Repair Regen. 1998 Jul-Aug;6(4):358-65
pubmed: 9824554
J Biol Chem. 1997 Jan 31;272(5):2722-8
pubmed: 9006910
Dev Cell. 2020 Nov 23;55(4):468-482.e7
pubmed: 33058779
Cell Rep. 2020 Nov 17;33(7):108396
pubmed: 33207197
Cell Mol Life Sci. 2018 Jun;75(11):1959-1971
pubmed: 29428964
Mol Cell Endocrinol. 1994 Oct;105(1):27-35
pubmed: 7821715
Trends Cell Biol. 2014 Oct;24(10):575-83
pubmed: 24933506
Bioessays. 1993 May;15(5):309-15
pubmed: 8393666
Biochem Soc Trans. 1994 Aug;22(3):575-9
pubmed: 7821640
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2938-43
pubmed: 20133701
Mol Cell Biol. 1997 Feb;17(2):644-55
pubmed: 9001218
Clin Cancer Res. 1999 Jul;5(7):1892-904
pubmed: 10430097
Nature. 2016 Oct 19;538(7625):336-343
pubmed: 27762356
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2321-5
pubmed: 1312717
Dev Dyn. 2008 Mar;237(3):736-49
pubmed: 18297730

Auteurs

Elena A Parshina (EA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.

Eugeny E Orlov (EE)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.

Andrey G Zaraisky (AG)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.
Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

Natalia Y Martynova (NY)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.
Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH